Regenerative medicine: the emergence of an industry.
Over the last quarter of a century there has been an emergence of a tissue engineering industry, one that has now evolved into the broader area of regenerative medicine. There have been 'ups and downs' in this industry; however, it now appears to be on a track that may be described as 'back to the future'. The latest data indicate that for 2007 the private sector activity in the world for this industry is approaching $2.5 billion, with 167 companies/business units and more than 6000 employee full time equivalents. Although small compared with the medical device and also the pharmaceutical industries, these numbers are not insignificant. Thus, there is the indication that this industry, and the related technology, may still achieve its potential and address the needs of millions of patients worldwide, in particular those with needs that currently are unmet.
Nerem
Robert M
RM
Parker H Petit Institute for Bioengineering and Bioscience, Georgia Tech/Emory Center for Regenerative Medicine, Georgia Institute of Technology, 315 Ferst Drive, NW, Atlanta, GA 30332-0363, USA. robert.nerem@ibb.gatech.edu
D049673:History, 20th Century; D049674:History, 21st Century; D007221:Industry / Q000191:economics / Q000266:history*; D044968:Regenerative Medicine / Q000191:economics / Q000266:history* / Q000639:trends; D057905:Stem Cell Research / Q000191:economics / Q000266:history; D023822:Tissue Engineering / Q000191:economics / Q000266:history* / Q000639:trends